SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " iop " 339 found 🔀 AI-powered Shuffle
Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing medicines that target the melanocortin receptor (MCR) system, today announced financial results for its fiscal third quarter ended March 31, 2026, and provided a business update.
Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights
MOUNTAIN VIEW, Calif., May 13, 2026--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for the quarter ended March 31, 2026, and highlighted recent progress across its pipeline of clinical-stage product candidates.
Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa
Avalere Health, a global strategic partner for the healthcare industry, today announces the launch of its Japan office. The move marks a significant expansion of Avalere Health's global footprint, and the launch of a new strategic offering is designed to support Japanese biopharmaceutical companies end-to-end across the product lifecycle.
Crystal Palace 2-2 Everton - send us your thoughts
Whether you were at the game or following from elsewhere, we want to know what you learned. Come back on Monday for a selection of your replies
East Africa Might Break Off From the Continent Sooner Than Scientists Thought—and a New Ocean May Fill the Gap
A new study suggests that a rift in Kenya and Ethiopia has reached a critical stage in the split-up process, and that water may flood it in a few million years
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
Advancing next-generation γδ T cell engager platform with initial animal data expected in 2026Reported glioblastoma (GBM) data showing ~97% improvement in progression-free survival vs. standard-of-care; updated median overall survival (mOS) data to be presented at ASCO 2026Hosting R&D Day on May 21, 2026 in New York City NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and γδ
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced the appointment of Nelson Azoulay as Chief Business Officer. Mr. Azoulay joins Pyxis Oncology with more than 15 years of experience in corporate strategy, business development, and value-creating transactions across the biopharma industry, including deep antibody-drug conjugate (ADC) experience. In his role,
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
/PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and...
Your guide to summer movies 2026: From 'Supergirl' to 'The Odyssey'
EW's guide to the biggest summer movie release dates, plus some exclusive new looks at movies like 'Supergirl,'
SeatGeek Partners with Beemok Sports & Entertainment to Power Cincinnati Open, Credit One Charleston Open
SeatGeek, the high-growth technology platform, announced a new partnership with Beemok Sports & Entertainment.
SeatGeek Partners with Beemok Sports & Entertainment to Power Cincinnati Open, Credit One Charleston Open
SeatGeek, the high-growth technology platform, announced a new partnership with Beemok Sports & Entertainment.
Enloe Health holds Nurses Making a Difference Award Ceremony during Nurses Week
Darrell Daugherty, a perioperative registered nurse at Enloe Health in Chico, has been named the second annual recipient of the health system’s Nurses Making a
Over half of Israeli adults are overweight or obese, Knesset Health Committee told
31.4% of 7th graders overweight; officials blame high cost of medications, inadequate health services in low-income areas, lack of accessible educational materials in Arab, Ethiopian sectors
Woman in cancer remission without treatment in highly unusual case
A biopsy of a woman's cancer seems to have triggered an immune response against the tumour, putting her into remission
UT Board of Trustees executives to talk Neyland Entertainment District
The University of Tennessee Board of Trustees Executive Committee will discuss Monday the future of a major Knoxville campus capital project: the Neyland Entertainment District.
2026 Best & Brightest MBA: Tania F. Davila Masciopinto, London Business School
Tania F. Davila Masciopinto, who is graduating from London Business School, has been named a Poets&Quants Best & Brightest MBA for 2026
Poll: Trump’s Iran war reaches Iraq- and Vietnam-era disapproval levels
A Post-ABC-Ipsos poll shows most Americans call the military action a mistake, even as Republicans remain strongly supportive. Many fear the conflict will lead to a recession.
FDA approves next-gen mitral valve from Medtronic
The Mosaic Neo mitral bioprosthesis can be implanted through sternotomy, minimally invasive cardiac surgery or robotic access.
New York Yankees @ Texas Rangers: Cam Schlittler vs. Jacob deGrom
The budding star will clash with an icon in Arlington.
Michael Jackson streams skyrocket after 'Michael' biopic opening weekend, up 95% in the US
Michael Jackson sang “Don’t Stop ’Til You Get Enough.” | Talk 1370
Michael Jackson streams skyrocket after 'Michael' biopic opening weekend, up 95% in the US
Michael Jackson sang “Don’t Stop ’Til You Get Enough.” | KMBZ
Audience Says: Michael Is Pure Entertainment for MJ Fans
The biopic is Verified Hot, with dazzled fans calling it the closest you can come to an actual Michael Jackson concert.
AMC Entertainment Scores a Thriller Weekend as MICHAEL Delivers a Record-Breaking Debut
AMC Entertainment once again welcomed global audiences in significant numbers to its theaters across the U.S. and internationally, as Michael moonwalked to the strongest biopic opening in box office history. These reported opening numbers for Michael include Friday through Sunday attendance figures, along with its Wednesday and Thursday preview screenings. As a result of the […]
Sun Pharma, Eli Lilly Lead Latest Rush of Healthcare M&A
The value of biopharma M&A has more than doubled his year.
'Michael' moonwalks into a big box office debut
"Michael," the Michael Jackson biopic from Lionsgate, had a massive opening weekend with a box office haul of $97 million in the U.S. and Canada. The film, which stars Jackson's
‘Michael’ moonwalks to $97 million opening, shattering record for music biopics
“Michael,” the big-budget Michael Jackson spectacle, shrugged off bad reviews and a troubled production to launch with $97 million in U.S. and Canada theaters, according to studio estimates Sunday, shattering a record debut for music biopics.
'Michael' moonwalks to $97 million opening, shattering record for music biopics
“Michael,” the big-budget Michael Jackson spectacle, shrugged off bad reviews and a troubled production to launch with $97 million in U.S. and Canada theaters, according to studio estimates Sunday, shattering a record debut for music biopics | WBBM Newsradio 780 AM & 105.9 FM
'Michael' moonwalks to $97 million opening, shattering record for music biopics
“Michael,” the big-budget Michael Jackson spectacle, shrugged off bad reviews and a troubled production to launch with $97 million in U.S. and Canada theaters, according to studio estimates Sunday, shattering a record debut for music biopics | KNSS Radio
'Michael' moonwalks to $97 million opening, shattering record for music biopics
“Michael,” the big-budget Michael Jackson spectacle, shrugged off bad reviews and a troubled production to launch with $97 million in U.S. and Canada theaters, according to studio estimates Sunday, shattering a record debut for music biopics | Talk 1370
'Michael' moonwalks to $97 million opening, shattering record for music biopics
“Michael,” the big-budget Michael Jackson spectacle, shrugged off bad reviews and a troubled production to launch with $97 million in U.S. and Canada theaters, according to studio estimates Sunday, shattering a record debut for music biopics | WBEN
Today’s Papers – Italian football shocked again, a new Calciopoli?
La Gazzetta dello SportRocchi under investigation for sports fraud: ‘He picked referees wanted by Inter’Calcio, another shockThe designator accused by the Milan Prosecutor: ‘I’ll suspend mysel...
Bad movies, good business: how sanitised biopics became a Hollywood staple
As the interest in the lives of celebrities has intensified, we have become acclimatised to the fact that they will now curate and mercilessly monetise it
$25 for Audiophile Earbuds? Meet Panasonic's New ErgoFit USB-C Wired Buds
These Panasonic wired earbuds sound remarkably good for their low price and also work well for voice calls. They earn a CNET Editors' Choice award for being an excellent value.
New movies to watch this weekend: See 'Michael' in theaters, rent 'Tow,' stream 'Apex' on Netflix
Is the Michael Jackson biopic any good? Jaafar Jackson deserves praise — but reviews are brutal.
New fee tied to UW Health’s 1 S. Park clinic change raises patient concerns
That shift means visits there will include a facility fee, an additional charge separate from a provider’s bill.
U.S. Forging a Healthier Oceania Through Trump Administration's America First Global Health Strategy Through Bilateral Health Memorandum of Understanding with Papua New Guinea - U.S. Embassy & Consulates in China
United States Forging a Healthier Oceania Through Trump Administration’s America First Global Health Strategy Through Bilateral Health Memorandum of Understanding with Papua New Guinea Press Statement Thomas “Tommy” Pigott, Principal Deputy Spokesperson April 23, 2026 Yesterday the United States and Papua New Guinea signed a five-year bilateral Memorandum of Understanding (MOU) through the Trump Administration’s America First Global Health Strategy. The landmark health MOU focuses on effectively addressing emerging infectious diseases and ongoing outbreaks, building and maintaining surge-response capacities, and enabling Papua New Guinea’s government to independently manage new health threats before they spread internationally. Working with Congress, the United States intends to provide $15 million through December 2030 through the jointly decided health MOU, building on decades of progress in reducing HIV infections and transmissions in Papua New Guinea. The government of Papua New Guinea intends to allocate up to $3 million to disease control programs and strengthen health systems at the national and provincial levels. Up to $5 million under the health MOU will directly support global health security funding, advancing our shared commitment to health security in the region. Through the signing of this $18 million MOU, we are bolstering infectious disease prevention and response by leveraging cost-effective, nationally-driven approaches, with the goal of increasing Papua New Guinea’s health system self-sufficiency. America First Global Health Strategy Memoranda of Understanding (MOUs) signed so far represent more than $20.6 billion in new health funding, including more than $12.8 billion in U.S. assistance alongside $7.8 billion in co-investment from recipient countries, building on decades of progress fighting HIV/AIDS, malaria, tuberculosis, and other infectious diseases around the world. As of April 22, the State Department has signed 32 bilateral global health MOUs with Angola, Bolivia, Botswana, Burkina Faso, Burundi, Cambodia, Cameroon, Côte d’Ivoire, the Democratic Republic of the Congo, the Dominican Republic, El Salvador, Eswatini, Ethiopia, Guatemala, Guinea, Honduras, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mozambique, Niger, Nigeria, Panama, Papua New Guinea, the Philippines, Rwanda, Senegal, Sierra Leone, Tajikistan, and Uganda.
Michael Jackson Biopic Cast Looks Shockingly Like The Real People They Play
"Michael," a film about the life and early career of the King of Pop, nailed it with these looks.
'Leaving Neverland' director says Michael Jackson was 'worse than Jeffrey Epstein,' fans want to forget abuse claims
'Leaving Neverland' director Dan Reed slammed the Michael Jackson biopic 'Michael' for ignoring allegations of child sexual abuse, and opined that the late 'Thriller' singer was 'worse than Jeffrey Epstein.'
Who Is John Branca? How the Entertainment Lawyer Launched Michael Jackson to Pop Superstardom
Miles Teller portrays Branca in the new biopic, ‘Michael,’ about Jackson’s life and early solo career.
Guitar Center Business Solutions Hosts Inaugural Tech Expo 'Resonate'
Guitar Center Business Solutions hosted its inaugural integrated technology expo Resonate at [...]
JPMorgan shuffles top health care bankers
The changes come as biopharma dealmaking roars back to life.
Janet and Paris Jackson skipped the 'Michael' premiere
Janet Jackson isn't portrayed in the 'Michael' biopic and she skipped the premiere along with Paris Jackson. Here's why they both bowed out and what the cast is saying about leaving sexual assault allegations on the cutting room floor.
A Music Biopic Supply Crisis Is Looming
As Hollywood continues to roll out films about seemingly every A-list classic rock and hip-hop artist, it's fair to wonder who will be left.
La Toya Jackson explains why Janet Jackson isn't in the 'Michael' biopic
Director Antoine Fuqua said that although she doesn't appear in "Michael," Janet Jackson still supports her nephew Jaafar Jackson, who stars as the King of Pop in the biopic.
Michael Jackson biopic premieres this week with mixed reviews
The "Michael" movie follows the "King of Pop," on and off stage and is set to premiere Friday, April 24. See what reviews say.
NBA play-in 2026: Suns emphatically end Warriors' season to claim West's final playoff spot, Magic advance in East
Complete Guide to Secrets of Strixhaven’s Mystical Archive Bonus Sheet
The plane of Arcavios is the home of the Biblioplex, a huge library that’s said to have all the known spells in the Multiverse. This is what inspired the first Strixhaven Mystical Archive, and for our return to Strixhaven, WotC saw fit to bring it back!
Volunteers Discover Rare Space Weather Events Using Their Ears
Scientists are working to understand exactly how these waves behave, and the team behind NASA’s Heliophysics Audified: Resonances in Plasmas (HARP) citizen science project approaches this in a unique way: they compare the Earth’s magnetic field to a giant harp in space.
Scientists Think They Could Design Entire Cities That Heal Your Brain
Biophilic designs—buildings that mimic natural forms—may help reduce psychological stress.
WATCH: New trailer, release date announced for \'Hershey\' biopic
In a bit of sweet news — there's a new trailer for the upcoming movie, "Hershey."
FDA accepts previously rejected application for new PET imaging agent
The radiopharma firm hopes to soon begin selling Pixclara (Floretyrosine F 18), an investigational product for glioma, a type of brain cancer.
Extra half-mile added to some runner’s course during Covenant Health Knoxville Marathon
The email said the lead vehicle took participants approximately a half mile longer than the advertised distance at the turnaround on Neyland Drive.
Kansas City health leaders announce new integrated theranostics research and treatment center
The center will unite diagnostics, molecular imaging, radiopharmaceutical production and targeted therapies under one coordinated platform.
Republican tells Trump to stop ‘nursing grudges’ as he complains NATO ‘wasn’t there when we needed them’
Trump suggested the U.S. may consider leaving the trans-Atlantic alliance.
Willson Contreras after being hit by Brewers: 'Next time they hit me again, I'm going to take one of them out'
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch
Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, AbbVie and others already use Claude in their operations.
Guardant Health (GH) Valuation Check After Strong 1 Year Return And Recent 90 Day Pullback
Guardant Health (GH) has drawn fresh attention as investors look at its recent share performance alongside its growing precision oncology business, including liquid biopsy tests and data services for cancer detection and treatment decisions. See our latest analysis for Guardant Health. At a latest share price of US$93.83, Guardant Health has seen a sharp 10.9% 7 day share price return and a 1 year total shareholder return above 100%. However, the 90 day share price return of a 7.77% decline...
Biophysicist Joins Ranks of Elite Scientists as AAAS Fellow
Dr. G. Andrés Cisneros has been recognized by the American Association for the Advancement of Science for his contributions to biophysics, computational enzymology and computational chemistry. Dr. G. Andrés Cisneros, professor and department head of physics at The University of Texas at Dallas, has been elected to the 2025 class of American Association for the […]
Iterative Health, US Heart & Vascular Partner to Advance Community-Based Cardiovascular Research
April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance research through community-based innovation in cardiovascular care. "Clinical research is one of the most powerful ways we expand access, improve patient outcomes, and shape the future of cardiovascular care," said Robbie Allen, chief executive officer of US Heart & Vascular. "By partnering with Iterative Health, we are strengthening our ability to bring innovative therapies directly into the communities we serve. This collaboration ensures our physicians and patients have access to leading-edge trials while allowing US Heart & Vascular to remain focused on delivering exceptional, physician-led care." Under the agreement, USHV research sites will join Iterative Health’s global site network, which now spans over 100 sites across three continents. The companies share a commitment to advancing clinical research as a driver of care innovation, and this collaboration represents a major milestone for both organizations, strengthening USHV's leadership in community-based cardiovascular research and expanding Iterative Health's multispecialty focus beyond GI, hepatology, and obesity into cardiology. USHV clinical research sites will gain access to Iterative Health's centralized operational backbone, providing end-to-end support across clinical research operations, services, business development, technology innovation, and corporate functions. The strategic partnership reduces operational complexity and unlocks growth potential for USHV research sites while enabling all USHV physicians to expand access to cutting-edge therapies to the thousands of patients they serve annually. "Innovation in cardiovascular medicine shouldn't be limited to a few academic centers," said Thomas Waggoner, DO, MD, RPVI, FACC, FSCAI, FSVM, RPVI, Structural Cardiologist and Medical Director for Clinical Research at Pima Heart & Vascular, and USHV Physician Champion for Clinical Research. "By expanding community-based research across USHV, we're ensuring more patients have access to clinical trials and breakthrough therapies close to home, where trusted relationships with their physicians already exist." This alliance reinforces Iterative Health's standing as the definitive research partner across specialized therapeutic areas, now spanning GI, hepatology, obesity, and cardiovascular care. Trusted by many of the nation's leading provider organizations and biopharma sponsors, Iterative Health's global site network delivers industry-leading trial performance, accelerating life-changing therapies to market at scale. "Entering cardiology through our strategic partnership with US Heart & Vascular is a defining moment for Iterative Health and reflects the strength of our site-serving model," said Jonathan Ng, founder and CEO of Iterative Health. "Together, we are ensuring that thousands of patients have access to the newest available therapies, and that sponsors have a credible, high-performing partner to accelerate cardiovascular trial success." For more information, visit www.iterative.health and https://usheartandvascular.com/.
Ex-Wisconsin tight end Jack Pugh dies
Pugh retired from football in 2023, citing his mental health.
KJ Apa Jimmy Stewart Biopic Sets November Release Date in Theaters
'Jimmy,' a biopic about Jimmy Stewart starring KJ Apa, is coming to theaters in November.
Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple
This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, according to a Deutsche Bank analyst.
Kim Novak says Sydney Sweeney is 'totally wrong' to play her in biopic, 'sticks out so much above the waist'
'Vertigo' star Kim Novak says Sydney Sweeney is 'totally wrong' to play her in the upcoming biopic 'Scandalous,' noting that she 'sticks out so much above the waist.'
Vanderbilt Lung Transplant Program sets new record
The Vanderbilt Transplant Center is now the second largest lung transplant center in the United States by volume, with 149 lung transplants in 2025, the most ever in one year at Vanderbilt Health. The Vanderbilt Lung Transplant Program leads the nation in organ preservation and regeneration and is among the best in long-term outcomes, demonstrating the success of the interdisciplinary team in caring for these complex patients. Several features make the program unique in the United States, said Konrad Hoetzenecker, MD, PhD, professor of Thoracic Surgery and surgical director of the Vanderbilt Lung Transplant Program. Vanderbilt serves as a “second opinion center” and accepts most complex candidates that are turned down by other centers due to increased perioperative risk. This includes patients over 70 years old, patients requiring combined procedures with their transplant, multiorgan transplantations and sensitized patients (individuals who have pre-formed anti-HLA antibodies who are at higher risk for complications). The expertise and excellent outcomes have attracted patients far beyond the borders of Tennessee; almost half of Vanderbilt Health’s lung transplant recipients come from out of state. “Another unique feature is our minimally invasive transplant program,” Hoetzenecker said. “By using distinct surgical instruments and techniques, the incisions can be kept as small as 7 to 8 centimeters, which results in better healing, less pain and faster recovery. “This minimally invasive approach is embedded in an Enhanced Recovery After Surgery (ERAS) protocol, a multimodal, evidence-based perioperative care pathway designed to reduce surgical stress, minimize complications and speed up recovery. Our unique ERAS protocol, by a dedicated interdisciplinary approach, aims to improve recovery after lung transplant and reduce ICU and hospital stay.” The lung transplant program recently celebrated a milestone — 1,000 lung transplants since the program began in 1990. “This significant achievement reflects the concerted effort of a multidisciplinary collaboration by the Departments of Thoracic Surgery, Medicine, Anesthesiology and Critical Care,” said David Erasmus, MD, associate professor of Medicine and medical director of Vanderbilt Lung Transplant. Lung transplants have been attempted since the 1960s, but they were largely unsuccessful until the 1980s, when surgical techniques were refined and new antirejection drugs proved effective. Patient outcomes steadily improved from the 1990s to the present. Vanderbilt’s fourth lung transplant recipient in 1990, Pam Everett, is the longest-living, single-lung transplant known in the world, recently celebrating 35 years since her transplant. The Vanderbilt Lung Transplant surgical team is led by Hoetzenecker and Caitlin Demarest, MD, PhD, the surgical director and associate surgical director of the Vanderbilt Lung Transplant program. Erasmus is the medical director of Vanderbilt Lung Transplant along with Anil Trindade, MD, associate medical director and associate professor of Medicine.
Grifols Plans IPO of U.S. Biopharma Business
The Spanish pharmaceutical company is looking to raise money to bolster its balance sheet and fund investments.
Grifols approves IPO of its US biopharma business
Healthcare company Grifols said on Tuesday it has approved a U.S. initial public offering of its U.S. biopharma business.
UCI Health lays off 150 workers as part of restructuring
UCI Health said the cuts were prompted by a changing environment that includes shifts in federal funding, reimbursement pressures and rising operational costs,
UFC London live blog: Movsar Evloev vs. Lerone Murphy
Follow along for live updates on Movsar Evloev vs. Lerone Murphy at UFC London
Louisville tops South Florida: Highlights and Postgame Videos
Feel free to watch every second of these, or turn the highlight videos off around the 9-minute mark of the second half. Either way, go ahead and soak this up. It’s been a while. Highlights: Pat Kelsey postgame from the bus: Locker room celebration:
Spotify adds ‘Exclusive Mode’ audiophile feature for Windows PCs
Spotify gets bit-perfect playback.
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness –CUE-401 is the Company’s lead asset for the treatment of autoimmune and inflammatory diseasesAppointed industry veteran Lucinda Warren as Chief Financial and Business OfficerRaised net proceeds of $10.2M through an underwritten public offeringAnnounced strategic collaboration and license agreement with ImmunoScape to develop breakthrough cell therapy approach for solid tumors – Entitled to receive upfront
Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights
MOUNTAIN VIEW, Calif., March 16, 2026--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for the full year ended December 31, 2025, and highlighted recent progress across its pipeline of clinical-stage product candidates.
Africa’s great divide: Why the continent’s split is so exciting for science
The African continent is splitting along a triple junction of rifts that converge in Afar, Ethiopia. A new ocean may take millions of years to form, but that is giving scientists ample time to glean important discoveries from one of the world’s most inhospitable regions.
DeGette challenger Melat Kiros trounces 15-term Democratic incumbent in Denver delegate vote
The 28-year-old, first-time candidate challenging Democratic U.S. Rep. Diana DeGette in this year’s primary soundly defeated the 15-term incumbent in a delegate preference poll conducted Saturday at a county party assembly in Denver. Melat Kiros, the daughter of Ethiopian immigrants and a former corporate attorney, received nearly twice as many votes as DeGette in a […]
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25
Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the Company will release full year 2025 financial results and provide business updates on Wednesday, March 25, 2026. The Company will host a conference call to discuss results that day at 4:30 PM ET.
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
Initiation of confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia is planned for Q2 2026, with topline data anticipated in 2H 2027BURLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today provided business updates and reported financial results for the fourth quarter and year ended Decembe
Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026
/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and...
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
GLEN ALLEN, Va., March 06, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2025 fiscal year ended December 31, 2025. Key Highlights: Regulatory Progress: Achieved positive clinical study results from the AD04-103 pharmacokinetics (P
World Birth Defects Day: “Behind every diagnosis is a story that deserves to be supported through strong public policies and strengthened health systems”
Interview with Pablo Durán, Regional Advisor on Perinatal and Neonatal Health at PAHOWashington, D.C., March 3, 2026 (PAHO) – Today marks World Birth Defects Day, an opportunity to raise awareness about a group of conditions that remain one of the leading causes of neonatal mortality and childhood disability in the Region of the Americas. Although many can be prevented or treated, thousands of families each year face diagnoses that require specialized care, continuous follow-up, and comprehensive support.
5 Of The Best Wired Headphones For Audiophiles, According To Users
These wired picks span budget to premium options for studio work, gaming, travel, and everyday listening — all with strong user feedback.
SGMC Health Announces Luke Parks as Administrative Director, Physician & Perioperative Business Services
SGMC Health announces the promotion of Luke Parks to Administrative Director, Physician & Perioperative Business Services
SGMC Health Announces Luke Parks as Administrative Director, Physician & Perioperative Business Services
SGMC Health announces the promotion of Luke Parks to Administrative Director, Physician & Perioperative Business Services
25th Navajo Nation Council
Delegate Johnson applauds Navajo Pine students’ innovation at science fair NAVAJO, N.M. –Council Delegate Casey Allen Johnson recently demonstrated his support for science, technology, engineering,...
Will Ethiopia be part of Israel’s ‘hexagon’ alliance rivalling its enemies?
Israeli President Herzog is in Addis Ababa days after high-level delegations from Turkiye and Saudi Arabia also visited.
Reading the enemy: How genome science is reshaping the fight against wheat stem rust
In 2013, farmers in the highlands of Ethiopia began to notice something unsettling: a familiar variety of wheat was failing in an unfamiliar way. Stems weakened, plants collapsed, and fields that had ...
Democrats decry meager medical care for detainees in funding fight
Fernando Viera Reyes needed a biopsy for possible prostate cancer when the Trump administration sent him to an immigration detention center in California’s Mojave Desert.
Vanderbilt Health remembers C. Leon Partain, former chair of Radiology
Clarence Leon Partain, MD, PhD, professor emeritus of Radiology and Radiological Sciences, whose work in nuclear medicine and magnetic resonance imaging helped shape the field of academic radiology, died Jan. 28 in Brentwood, Tennessee. He was 85. After beginning his career as a nuclear engineer at Oak Ridge National Laboratory and as faculty at the University of Missouri and the University of North Carolina, Dr. Partain joined the ranks at Vanderbilt Radiology in 1980 and was promoted to professor in 1984. He later became the first Carol D. and Henry P. Pendergrass Professor of Radiology and Radiological Sciences and chair of the department (1992-2000), and subsequently the director of the Center for Imaging Research. Shortly after arriving in Nashville, Dr. Partain began to lead Vanderbilt Radiology’s nuclear medicine division. He remained in this role until he was named the department chair. Dr. Partain specialized in multiple fields, including nuclear medicine, magnetic resonance imaging and positron emission tomography. Following his time as chair, Dr. Partain shifted his focus to research and spent time working clinically with radiology’s chest imaging section. In 2015, he retired and was honored for his years of service and named as emeritus faculty. Dr. Partain also held an appointment as professor of Biomedical Engineering. A Tennessee native, Dr. Partain was born in Memphis and later graduated from high school in Clarksville. He then received his BS in nuclear engineering from the University of Tennessee, his MS and PhD in nuclear engineering from Purdue University and his MD from Washington University. He completed his residency training in diagnostic radiology and nuclear medicine at the University of North Carolina. Dr. Partain was clinically trained and certified in diagnostic radiology and nuclear radiology by the American Board of Radiology (ABR) and the American Board of Nuclear Medicine. Throughout his career, Dr. Partain contributed to the growth of Vanderbilt Radiology and received many academic and research accolades across the specialty through various associations. During his time leading the department, clinical studies increased from 180,000 to 260,000 cases per year, emerging technological imaging equipment expanded the department’s capabilities, and units for angiography and fluoroscopy were added to the tool kit. The department also expanded its footprint with outpatient imaging in Nashville, Bedford County and more. Research continued to expand with continued growth in scientific findings and millions in grant funding for radiopharmaceuticals, functional MRI, nuclear medicine, X-ray, ultrasound and more. Dr. Partain is celebrated for being instrumental in bringing the first MRI and PET/CT machines to the Medical Center. His efforts helped build Vanderbilt Radiology’s prestige in the world of academics and research both nationally and internationally. His society affiliations included the American College of Radiology, the American College of Nuclear Medicine, and the International Society of Magnetic Resonance in Medicine (ISMRM). He served as president of the Radiological Research Alliance of the Association of Academic Radiologists and has held executive roles as a member of many radiological society boards. Dr. Partain was editor-in-chief of the Journal of Magnetic Resonance Imaging from 2000 to 2013 and a member of the editorial boards of Magnetic Resonance in Medicine, Magnetic Resonance Imaging, the American Journal of Roentgenology, Academic Radiology, the Journal of Nuclear Medicine and Investigative Radiology. He has authored/co-authored/edited six textbooks, including one of the first comprehensive textbooks on MRI, “Nuclear Magnetic Resonance (NMR) Imaging.” Dr. Partain has also authored/co-authored/edited approximately 100-plus book chapters and 200-plus journal articles. In 2000, Dr. Partain received the Distinguished Service Award from the ABR. In 2014, he received the Distinguished Service Award from the ISMRM. In 2016, he received the Alumni Achievement Award from Washington University for his “contributions to advance the fields of nuclear medicine and medical imaging.” Dr. Partain served the ABR as an examiner for 20 years, the Accreditation Council for Graduate Medical Education as a member of the Nuclear Medicine Residency Review Committee, and Vanderbilt University School of Medicine in multiple capacities. A devout Baptist deacon and man of committed faith, he is survived by his wife of 62 years, Judy; children, David (Rebecca), Teri (Bland), and Amy; brother, Larry (Deb); brother-in-law, Tom (Cathy); grandchildren, Sarah (Brandon), Amy, Luke, Tucker, Alex, Ryan and Jake; cousins and a host of nieces and nephews. Vanderbilt Health is grateful to Dr. Partain for his decades of service and major contributions to clinical and research imaging.
12 Of The Best Record Players For Audiophiles
Some say nothing sounds like a vinyl. There's enough interest in that theory to support a wide market of modern record players suitable for every audiophile.
[Press release] Weizmann Institute of Science: Gut microbes actively support immunity in people living with HIV
A study conducted in Israel and Ethiopia revealed that the microbiome partly compensates for the immune damage caused by HIV.
Building biopharma: The communities behind the science
Editor’s note: This is the first of a twice-monthly series that will highlight the vibrant communities that make up the biopharma industry. | What began as a small summit of women biotech CEOs five years ago has grown into a 350-member force gaining momentum, even as political headwinds force others to retreat.
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, today announced that Lucinda Warren, who has served as Cue Biopharma’s chief business officer (CBO) since September 2024, has been appointed chief financial and business officer (CFBO) effective February 9, 2026
Amendment 47: Corrections to B.2 Heliophysics Foundational Research
B.2 Heliophysics Foundational Research (HFR) solicits investigations that advance the fundamental physical understanding of the Sun-Heliosphere-Planetary
Google parent Alphabet forecasts sharp surge in 2026 capital spending
Alphabet said on Wednesday it was targeting capital expenditure of $175 billion to $185 billion this year, in yet another aggressive ramp-up in spending from the Google parent as it deepens its investments to push ahead in the AI race.
Spotlight on Business: 25 years of therapy, Ethiopian and Cuban-inspired restaurants opening
In this week's Spotlight on Business, we're highlighting a therapy clinic celebrating 25 years in the Med City, and two new restaurants opening in Rochester.
Amendment 44: Final Text for B.2 Heliophysics Foundational Research
B.2 Heliophysics Foundational Research (HFR) solicits investigations that advance the fundamental physical understanding of the Sun-Heliosphere-Planetary
Maryland Companies Celebrate Global Collaborations, Industry Honors and Local Partnerships
The Maryland Marketing Partnership, which helps drive Maryland's branding and marketing efforts to attract businesses, create jobs, and grow the state's economy, today shared a summary of the latest news from companies and organizations that invest in the partnership. "Maryland's marketing partners are starting the year with major investments in our state's workforce and economy," said Harry Coker Jr., Secretary for the Maryland Department of Commerce. "From clean energy to biopharma to higher education to commercial real estate, these investments are helping us build a stronger and more competitive Maryland economy." BGE , Maryland's largest natural gas and electric utility, along with the Exelon Foundation , announced a $250,000 grant for Civic Works' Baltimore Shines solar initiative to support solar installations for 30 homes in Baltimore. According to Civic Works, homeowners will receive free rooftop solar installations, adding clean energy to the grid and generating more than
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland China
SHANGHAI, February 01, 2026--GAH and Tenacia announce a China commercialization partnership for ZTALMY, the first approved therapy for CDKL5 deficiency disorder.
Louisiana company that turns placentas into skin grafts pivots to 3D bioprinter business
Placentas are processed into wound-care patches resembling Listerine breath strips.
Here’s What The New Bruce Springsteen Biopic Gets Right — And Where It Falls Short
Jeremy Allen White has a quiet intensity in this Bruce Springsteen biopic — which soars when it actually focuses on the man behind the music.